Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action.

Several aromatic/heterocyclic sulfonamide scaffolds have been used to synthesize compounds incorporating NO-donating moieties of the nitrate ester type, which have been investigated for the inhibition of five physiologically relevant human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms: hCA I (offtarget), II, IV and XII (antiglaucoma targets) and IX (antitumor target). Some of the new compounds showed effective in vitro inhibition of the target isoforms involved in glaucoma, and the X-ray crystal structure of one of them revealed factors associated with the marked inhibitory activity. In an animal model of ocular hypertension, one of the new compounds was twice more effective than dorzolamide in reducing elevated intraocular pressure characteristic of this disease, anticipating their potential for the treatment of glaucoma.

[1]  C. Supuran,et al.  Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. , 2005, Bioorganic & medicinal chemistry letters.

[2]  C. Supuran,et al.  Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. , 2004, Journal of enzyme inhibition and medicinal chemistry.

[3]  C. Supuran,et al.  Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). , 2008, Bioorganic & medicinal chemistry letters.

[4]  C. Supuran,et al.  Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II. , 2010, Bioorganic & medicinal chemistry letters.

[5]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[6]  H. Vapaatalo,et al.  Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits , 2003, Current eye research.

[7]  C. Supuran,et al.  Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. , 2010, Bioorganic & medicinal chemistry letters.

[8]  M. Lerman,et al.  Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma , 2003, Journal of medical genetics.

[9]  Ronald J. Quinn,et al.  Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. , 2009, Journal of the American Chemical Society.

[10]  C. Supuran,et al.  Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV. , 2010, Bioorganic & medicinal chemistry letters.

[11]  C. Supuran,et al.  Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. , 2005, Bioorganic & medicinal chemistry letters.

[12]  C. Supuran,et al.  Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations. , 2010, Bioorganic & medicinal chemistry.

[13]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? , 1999, Journal of medicinal chemistry.

[14]  C. Supuran,et al.  Drug design of Zinc-enzyme inhibitors: functional, structural and disease applications , 2009 .

[15]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[16]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. , 2005, Bioorganic & medicinal chemistry letters.

[17]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors. Inhibition of Cytosolic Isozymes I and II and Transmembrane, Cancer-associated Isozyme IX with Lipophilic Sulfonamides , 2003, Journal of enzyme inhibition and medicinal chemistry.

[18]  Andrea Scozzafava,et al.  Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II. , 2005, Journal of medicinal chemistry.

[19]  W. Sly,et al.  Carbonic anhydrase XIV: luminal expression suggests key role in renal acidification. , 2002, Kidney international.

[20]  N. Carter.  Carbonic anhydrase: From biochemistry and genetics to physiology and clinical medicine : Edited by F. Botrè, G. Gros and B.T. Storey; VCH Verlag; Weinheim, 1991; xvi + 467 pages. DM 186.00, £70.00. ISBN 352728365x , 1992 .

[21]  C. Supuran,et al.  Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. , 2010, Journal of medicinal chemistry.

[22]  C. Supuran,et al.  Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides , 2010, Journal of enzyme inhibition and medicinal chemistry.

[23]  C. Supuran,et al.  Antiglaucoma Carbonic Anhydrase Inhibitors as Ophthalomologic Drugs , 2009 .

[24]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[25]  C. Supuran,et al.  Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide. , 2004, Bioorganic & medicinal chemistry letters.

[26]  C. Supuran,et al.  Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. , 2003, Bioorganic & medicinal chemistry letters.

[27]  R. Khalifah,et al.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.

[28]  C. Supuran,et al.  Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma. , 2009, Bioorganic & medicinal chemistry letters.

[29]  P. Lambin,et al.  Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies , 2009, Journal of enzyme inhibition and medicinal chemistry.

[30]  C. Supuran,et al.  7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. , 2010, Bioorganic & medicinal chemistry letters.

[31]  E. Masini,et al.  Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma , 2004, British Journal of Ophthalmology.

[32]  Andrea Scozzafava,et al.  Carbonic anhydrase IX: A new druggable target for the design of antitumor agents , 2008, Medicinal research reviews.

[33]  C. Supuran.  Carbonic Anhydrases as Drug Targets: General Presentation , 2009 .

[34]  C. Supuran,et al.  Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits. , 2004, Bioorganic & medicinal chemistry letters.

[35]  C. Supuran,et al.  Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. , 2010, Chemical communications.

[36]  K. Kaila,et al.  Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. , 2010, Journal of medicinal chemistry.

[37]  T. Owa,et al.  Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. , 2004, Bioorganic & medicinal chemistry letters.

[38]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[39]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors. Inhibition of Cytosolic Isozymes I and II and Transmembrane, Cancer-associated Isozyme IX with Anions , 2003, Journal of enzyme inhibition and medicinal chemistry.

[40]  A. Scaloni,et al.  Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX , 2009, Proceedings of the National Academy of Sciences.

[41]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic/heterocyclic sulfonamides: is the tail more important than the ring? , 1999, Journal of enzyme inhibition.

[42]  Claudiu T Supuran,et al.  Carbonic anhydrase inhibitors. , 2003, Bioorganic & medicinal chemistry letters.